We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+6.5%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$11.8B
AUM Growth
+$485M
Cap. Flow
-$250M
Cap. Flow %
-2.12%
Top 10 Hldgs %
39.85%
Holding
1,230
New
34
Increased
603
Reduced
253
Closed
43

Sector Composition

Rank Sector Weight
1 Real Estate 73.1%
2 Technology 4.03%
3 Financials 3.16%
4 Industrials 2.98%
5 Healthcare 2.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AIMT
1026
DELISTED
Aimmune Therapeutics
AIMT
$8K ﹤0.01%
395
MNTA
1027
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$8K ﹤0.01%
626
BOLD
1028
DELISTED
Audentes Therapeutics, Inc
BOLD
$8K ﹤0.01%
290
+19
+7% +$648
EDIT icon
1029
Editas Medicine
EDIT
$407M
$7K ﹤0.01%
304
ENTA icon
1030
Enanta Pharmaceuticals
ENTA
$377M
$7K ﹤0.01%
124
INVA icon
1031
Innoviva
INVA
$1.6B
$7K ﹤0.01%
645
+48
+8% +$574
MTCH icon
1032
Match Group
MTCH
$9.08B
$7K ﹤0.01%
100
-200
-67% -$15.6K
SGMO
1033
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$7K ﹤0.01%
726
TBPH icon
1034
Theravance Biopharma
TBPH
$875M
$7K ﹤0.01%
353
VCYT icon
1035
Veracyte
VCYT
$4.47B
$7K ﹤0.01%
297
ZLAB icon
1036
Zai Lab
ZLAB
$2.12B
$7K ﹤0.01%
222
+90
+68% +$3.09K
RDUS
1037
DELISTED
Radius Health, Inc.
RDUS
$7K ﹤0.01%
290
RARX
1038
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$7K ﹤0.01%
300
+33
+12% +$978
AMPH icon
1039
Amphastar Pharmaceuticals
AMPH
$841M
$6K ﹤0.01%
296
ANAB icon
1040
AnaptysBio
ANAB
$1.61B
$6K ﹤0.01%
172
ANIP icon
1041
ANI Pharmaceuticals
ANIP
$1.79B
$6K ﹤0.01%
76
ESPR
1042
DELISTED
Esperion Therapeutics
ESPR
$6K ﹤0.01%
171
FATE icon
1043
Fate Therapeutics
FATE
$281M
$6K ﹤0.01%
410
TXMD icon
1044
TherapeuticsMD
TXMD
$24M
$6K ﹤0.01%
31
SPPI
1045
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$6K ﹤0.01%
706
ATNX
1046
DELISTED
Athenex, Inc. Common Stock
ATNX
$6K ﹤0.01%
25
+4
+19% +$1.31K
AERI
1047
DELISTED
Aerie Pharmaceuticals
AERI
$6K ﹤0.01%
289
EPZM
1048
DELISTED
Epizyme, Inc
EPZM
$6K ﹤0.01%
571
DRNA
1049
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$6K ﹤0.01%
436
+37
+9% +$529
LMNX
1050
DELISTED
Luminex Corp
LMNX
$6K ﹤0.01%
284

Similar funds

Daiwa Securities Group's Q3 2019 Portfolio in Review

As of Q3 2019, Daiwa Securities Group held 1,230 positions worth $11.8B, up 4.3% from $11.3B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Daiwa Securities Group's Q3 2019 filing shows 34 new, 603 increased, 253 reduced and 43 closed positions. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 42,579 shares worth $12.6M. The largest sale was Public Storage, an estimated $190M.

By sector, the portfolio is most concentrated in Real Estate at 73% of assets, up from 72% a quarter earlier, followed by Technology and Financials.

  • Daiwa Securities Group's largest Q3 2019 buy was State Street SPDR S&P 500 ETF Trust: 42,579 shares worth $12.6M.
  • Daiwa Securities Group added most to Realty Income in Q3 2019, an estimated $211M increase.
  • Daiwa Securities Group's biggest Q3 2019 reduction was Public Storage, cutting an estimated $190M.
  • Daiwa Securities Group fully exited Coupa Software Incorporated in Q3 2019, selling an estimated $4.17M.
  • Daiwa Securities Group's ten largest holdings make up 40% of its $11.8B portfolio in Q3 2019.
  • Daiwa Securities Group opened 34 new positions and closed 43 in Q3 2019.
  • Daiwa Securities Group's portfolio value rose 4.3% quarter-over-quarter to $11.8B.

Based on Daiwa Securities Group's 13F filing for Q3 2019, filed 4 Nov 2019.